SARS-CoV-2 Spike Trimerbody could represent a therapeutic option for COVID-19.
We are glad to report that in a recently published EMBO Journal paper “Neutralization of SARS-CoV-2 by highly potent, hyperthermostable, and mutation-tolerant nanobodies” (https://doi.org/10.15252/embj.2021107985) the authors suggest that a Trimerbody against the receptor-binding domain (RBD) of the […]